about us
CEO Message
Leadership
Company Overview
History
Investors
technology
PHENOTYPIC SCREENING
TARGET ID/MOA
PROTEOMICS/BIOMARKER
pDOS
SEOUL-FLUOR
FITGE/TS-FITGE
Molecular Splitter for TPU
R&D
Research Interest
Disease Area
Pipeline
order
Bioprobe
media
Press
News
Gallery
Reference
contact us
Location
Tel. +82-2-887-9090
media
spark biopharma
스파크바이오파마, 250억원 규모 ‘시리즈C’ 투자유치 완료
작성자 :
관리자
등록일 : 2022.04.04
조회수
1,006
링크 :
https://www.hankyung.com/it/article/202204040980i
목록